1. Home
  2. RGNX vs BMRC Comparison

RGNX vs BMRC Comparison

Compare RGNX & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • BMRC
  • Stock Information
  • Founded
  • RGNX 2008
  • BMRC 1989
  • Country
  • RGNX United States
  • BMRC United States
  • Employees
  • RGNX N/A
  • BMRC N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • BMRC Major Banks
  • Sector
  • RGNX Health Care
  • BMRC Finance
  • Exchange
  • RGNX Nasdaq
  • BMRC Nasdaq
  • Market Cap
  • RGNX 387.0M
  • BMRC 343.8M
  • IPO Year
  • RGNX 2015
  • BMRC N/A
  • Fundamental
  • Price
  • RGNX $9.49
  • BMRC $22.05
  • Analyst Decision
  • RGNX Strong Buy
  • BMRC Strong Buy
  • Analyst Count
  • RGNX 8
  • BMRC 3
  • Target Price
  • RGNX $31.75
  • BMRC $26.67
  • AVG Volume (30 Days)
  • RGNX 1.3M
  • BMRC 94.8K
  • Earning Date
  • RGNX 07-31-2025
  • BMRC 07-28-2025
  • Dividend Yield
  • RGNX N/A
  • BMRC 4.63%
  • EPS Growth
  • RGNX N/A
  • BMRC N/A
  • EPS
  • RGNX N/A
  • BMRC N/A
  • Revenue
  • RGNX $156,718,000.00
  • BMRC $70,630,000.00
  • Revenue This Year
  • RGNX $313.52
  • BMRC $69.47
  • Revenue Next Year
  • RGNX N/A
  • BMRC $9.30
  • P/E Ratio
  • RGNX N/A
  • BMRC N/A
  • Revenue Growth
  • RGNX 80.70
  • BMRC N/A
  • 52 Week Low
  • RGNX $5.04
  • BMRC $14.44
  • 52 Week High
  • RGNX $15.36
  • BMRC $27.11
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 49.21
  • BMRC 60.24
  • Support Level
  • RGNX $7.95
  • BMRC $21.36
  • Resistance Level
  • RGNX $11.00
  • BMRC $21.98
  • Average True Range (ATR)
  • RGNX 0.95
  • BMRC 0.72
  • MACD
  • RGNX -0.10
  • BMRC 0.10
  • Stochastic Oscillator
  • RGNX 28.52
  • BMRC 85.88

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About BMRC Bank of Marin Bancorp

Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties and others. The majority of its revenue comes from interest income.

Share on Social Networks: